Author

Kristen Syvertsen

Observed name: Syvertsen, Kristen

Institution: International AIDS Vaccine Initiative

Observed institution: International AIDS Vaccine Initiative

ORCID: 0009-0008-0816-2203

Observed ORCID: 0009-0008-0816-2203

OpenAlex ID: A5085575181

Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans

2025 · Jordan R. Willis, Madhu Prabhakaran, et al. · Science · 100

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults

2015 · Juliet Mpendo, Gaudensia Mutua, et al. · PLoS ONE · 43

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults

2015 · Gloria Omosa-Manyonyi, Juliet Mpendo, et al. · PLoS ONE · 37

Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G (NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers

2014 · Etienne Karita, Omu Anzala, et al. · AIDS Research and Human Retroviruses · 4

Translating Innovation to Clinic: End‐to‐End Bioprocess Development and cGMP Manufacturing of N332‐GT5 HIV Vaccine Candidate for First‐In‐Human Trials (HVTN144)

2026 · Sammaiah Pallerla, Shaunak D. Uplekar, et al. · Biotechnology and Bioengineering · 1

Works count: 6

Citation count: 185

H-index: 4

I10-index: 3